A complete response in metastatic malignant thymoma to cis-platinum, doxorubicin and cyclophosphamide: a case report.
Systemic chemotherapy as a mode of therapy in metastatic malignant thymoma has never been systematically evaluated. Chemotherapeutic agents, including doxorubicin, cyclophosphamide, cis-platinum, nitrogen mustard, prednisone or combination of agents like MOPP have produced tumor remission. A case report of complete remission of malignant thymoma in which the combination of cyclophosphamide, doxorubicin and cis-platinum (CAP) was used is reported.
D002945:Cisplatin / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D008479:Mediastinal Neoplasms / Q000473:pathology; D013945:Thymoma / Q000188:drug therapy / Q000556:secondary*
D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin